Covid 19 — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for covid 19. 2 active patents protecting 1 drugs from 1+ originators. First major cliff: 2041. Daily refresh.

1
Approved drugs
2
Active US patents
70/100
Avg vulnerability
—
Annual revenue covered

Originators in Covid 19

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Pfizer 2 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating covid 19. Each bar = one year. Y-axis scaled to peak year (1 patents).

No expiries in next 15 years.

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Paxlovid (Copackaged)
Nirmatrelvir
 Pfizer 2 70 — 2041-08-05

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
11351149 Paxlovid (Copackaged) method of use 70 2041-08-05
11541034 Paxlovid (Copackaged) method of use 70 2041-10-31

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
11541034 Paxlovid (Copackaged) method of use 70 2041-10-31
11351149 Paxlovid (Copackaged) method of use 70 2041-08-05

Related